Co-targeting BCL-X(L) and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice

Small-cell lung cancer (SCLC) is an aggressive malignancy with limited therapeutic options. The dismal prognosis in SCLC is in part associated with an upregulation of BCL-2 family anti-apoptotic proteins, including BCL-X(L) and MCL-1. Unfortunately, the currently available inhibitors of BCL-2 family...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Sajid, Kellish, Patrick, Connis, Nick, Thummuri, Dinesh, Wiegand, Janet, Zhang, Peiyi, Zhang, Xuan, Budamagunta, Vivekananda, Hua, Nan, Yang, Yang, De, Umasankar, Jin, Lingtao, Zhang, Weizhou, Zheng, Guangrong, Hromas, Robert, Hann, Christine, Zajac-Kaye, Maria, Kaye, Frederic J., Zhou, Daohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806104/
https://www.ncbi.nlm.nih.gov/pubmed/36588105
http://dx.doi.org/10.1038/s41420-022-01296-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806104/
https://www.ncbi.nlm.nih.gov/pubmed/36588105
http://dx.doi.org/10.1038/s41420-022-01296-8

Ejemplares similares